PRRT2 and breast cancer: Members of the PKC family are known to influence proliferation, differentiation, apoptosis, cellular motility, and angiogenesis (1, 4), leading us to hypothesize that loss of PKCβ would cause decreased mammary tumorigenesis in the MMTV–PyMT mammary tumor model.